This increased expression was further associated with the resistance to heart failure, by reducing thrombospondin-1 (THSP-1) and connective tissue growth factor (CTGF), the two direct targets of members of the miR-17–92 cluster (22). The gene discussed is CCN2; the disease is heart failure.